Breaking News Instant updates and real-time market news.

SIGA

Siga Technologies

$5.35

-0.33 (-5.81%)

, PFE

Pfizer

$41.53

-0.37 (-0.88%)

07:36
06/03/19
06/03
07:36
06/03/19
07:36

Siga Technologies enters promotion agreement with Meridian for TPOXX

Siga Technologies (SIGA) announced that it has entered into an international promotion agreement with Meridian, a Pfizer (PFE) company. Under the agreement, Meridian will promote the sale of oral TPOXX for the treatment of smallpox in all markets, except for the United States and South Korea. Siga will continue to be the owner of all rights in the U.S. market. Under the terms of the agreement, Meridian has exclusive rights and responsibilities to market and sell oral TPOXX in all geographic regions except for the U.S. and South Korea, and SIGA retains ownership, distribution and supply rights and regulatory responsibilities in connection with TPOXX. The agreement does not include any cash payments at signing, and both parties are responsible for the costs of their respective activities. Meridian will be compensated under the promotion agreement through a fee that will be based on a percentage of net sales of oral TPOXX.

SIGA

Siga Technologies

$5.35

-0.33 (-5.81%)

PFE

Pfizer

$41.53

-0.37 (-0.88%)

SIGA Siga Technologies
$5.35

-0.33 (-5.81%)

PFE Pfizer
$41.53

-0.37 (-0.88%)

05/28/19
PIPR
05/28/19
NO CHANGE
PIPR
Piper more bullish on GlycoMimetics, Global Blood into upcoming catalysts
After surveying 25 sickle cell disease experts, Piper Jaffray analyst Danielle Brill is "incrementally more bullish" on both GlycoMimetics (GLYC) and Global Blood Therapeutics (GBT) into their upcoming catalysts. GlycoMimetics and partner Pfizer (PFE) have pivotal Phase 3 results with rivipansel, their pan-selectin inhibitor, reading out in July, Brill tells investors in a research note. And Global Blood Therapeutics is expected to complete its new drug application submission for voxelotor via the accelerated approval pathway and present full Phase 3 Hope trial data in June, adds the analyst. Following expert feedback, Brill remains confident for a successful Phase 3 outcome with rivipansel. She believes positive data will drive GlycoMimetics shares "meaningfully higher" in July. Further, the majority of the surveyed doctors believe voxelotor's hemolytic anemia benefit is clinically relevant and most expect accelerated approval based on these data, adds the analyst.
05/28/19
GSCO
05/28/19
INITIATION
Target $49
GSCO
Conviction Buy
Pfizer initiated with a Conviction Buy at Goldman Sachs
Goldman Sachs analyst Terence Flynn started Pfizer with a Buy rating and added the shares to his firm's Americas Conviction List. He has a $49 price target for the shares. Flynn expects Pfizer's growth to inflect in 2021 with revenue of $57.4B, ahead of the $56B consensus estimate. He also projects the company's operating margins will expand from 38.1% in 2019 to 40.6% in 2022 as revenue growth outpaces expenses.
05/29/19
CANT
05/29/19
NO CHANGE
Target $53
CANT
Overweight
Pfizer sales potential Vyndaqel/Vyndamax underappreciated, says Cantor
Cantor Fitzgerald analyst Louise Chen says her "quick poll" of cardiologists supports the view that the peak sales potential of Pfizer's Vyndaqel/Vyndamax is underappreciated. The sales could be "meaningfully higher" than the 2024 consensus forecasts of $1.5B given a treatment cost of $225,000 per patient per year and a potential treatment population of 1M-plus in the U.S., Chen tells investors in a research note. She thinks the growing usage of scintigraphy for diagnosing transthyretin amyloid cardiomyopathy will increase the number of patients that are identified and eligible for treatment. The analyst reiterates an Overweight rating on Pfizer with a $53 price target.
05/30/19
GUGG
05/30/19
NO CHANGE
GUGG
Buy
Array BioPharma could be seen as target after 'de-risking' data, says Guggenheim
Guggenheim analyst Michael Schmidt said Array Biopharma (ARRY) may be perceived by investors as a theoretical acquisition target following the disclosure of Phase 3 interim results of Braftovi/Mektovi in BRAF+ colorectal cancer, which he views as positive and a "de-risking event." 67% of announced acquisitions in oncology with a comparable market cap to Array had what he would consider major pipeline de-risking events in the 6 months prior to their deal announcements, Schmidt tells investors. Merck (MRK) and Pfizer (PFE) "seem to have most bandwidth for a deal," said Schmidt, who added that those two along with Bristol-Myers (BMY), AstraZeneca (AZN) and Roche (RHHBY) scored highest as possible large cap theoretical acquirers of Array in his analysis. Schmidt raised his price target on Array Biopharma shares to $38 from $37, though his analysis suggests a potential $40-$50 acquisition price if the company were to be bought.

TODAY'S FREE FLY STORIES

ERJ

Embraer

$16.89

-0.13 (-0.76%)

14:05
10/21/19
10/21
14:05
10/21/19
14:05
Hot Stocks
Flexjet announces $1.4B jet order from Embraer »

Flexjet announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

PTON

Peloton

$22.69

-0.75 (-3.20%)

14:05
10/21/19
10/21
14:05
10/21/19
14:05
Initiation
Peloton initiated  »

Correction: Peloton…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUYA

Huya

$22.02

0.555 (2.59%)

14:05
10/21/19
10/21
14:05
10/21/19
14:05
Options
HUYA call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BB

BlackBerry

$5.21

0.125 (2.46%)

14:04
10/21/19
10/21
14:04
10/21/19
14:04
Hot Stocks
BlackBerry promotes McClurg to CISO, Hummel to CIO »

BlackBerry Limited has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 19

    Nov

BA

Boeing

$330.16

-13.93 (-4.05%)

14:03
10/21/19
10/21
14:03
10/21/19
14:03
Periodicals
Boeing CEO cites 'steady progress' on 737 MAX in internal email, Reuters says »

Boeing CEO Dennis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$330.72

-13.37 (-3.89%)

14:00
10/21/19
10/21
14:00
10/21/19
14:00
Periodicals
EASA sees Boeing 737 MAX being cleared in January 'at earliest,' Reuters says »

The head of Europe's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

TEVA

Teva

$7.75

0.25 (3.33%)

13:58
10/21/19
10/21
13:58
10/21/19
13:58
Hot Stocks
Teva settles Ohio opioid cases, has framework in place to settle remaining cases »

Teva Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 07

    Dec

F

Ford

$9.03

0.035 (0.39%)

13:58
10/21/19
10/21
13:58
10/21/19
13:58
Hot Stocks
Ford to spend more than self-driving commitment of $4B through 2023 »

Jim Farley, Ford's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

TSCO

Tractor Supply

$92.65

-0.71 (-0.76%)

13:55
10/21/19
10/21
13:55
10/21/19
13:55
Options
Tractor Supply put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 13

    Nov

KSU

Kansas City Southern

$146.92

1.54 (1.06%)

13:51
10/21/19
10/21
13:51
10/21/19
13:51
Recommendations
Kansas City Southern analyst commentary  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

KGJI

Kingold Jewelry

$0.56

-0.0212 (-3.62%)

13:48
10/21/19
10/21
13:48
10/21/19
13:48
Hot Stocks
Kingold Jewelry announces 1-for-6 reverse split of common stock »

Kingold Jewelry announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKAM

Akamai

$91.72

0.15 (0.16%)

13:35
10/21/19
10/21
13:35
10/21/19
13:35
Hot Stocks
Akamai says peak traffic on Akamai intelligent edge platform exceeds 100 Tbps »

Akamai announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 05

    Nov

  • 06

    Nov

  • 19

    Nov

  • 09

    Dec

VRTX

Vertex

$176.23

-0.01 (-0.01%)

13:29
10/21/19
10/21
13:29
10/21/19
13:29
Hot Stocks
Vertex says Spanish government approves national reimbursement of CF combos »

Vertex Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

STRM

Streamline Health

$1.20

0.02 (1.69%)

, AGO

Assured Guaranty

$47.16

0.28 (0.60%)

13:19
10/21/19
10/21
13:19
10/21/19
13:19
On The Fly
Fly Insider: Streamline, Proofpoint among week's notable insider trades »

Welcome to "Fly Insider,"…

STRM

Streamline Health

$1.20

0.02 (1.69%)

AGO

Assured Guaranty

$47.16

0.28 (0.60%)

TAYD

Taylor Devices

$10.72

0.21 (2.00%)

CMCT

CIM Commercial Trust

$14.70

0.1 (0.68%)

ATNX

Athenex

$9.81

-0.39 (-3.82%)

OKTA

Okta

$101.00

2.32 (2.35%)

LRCX

Lam Research

$239.22

5.56 (2.38%)

FISV

Fiserv

$104.30

-1.41 (-1.33%)

PFPT

Proofpoint

$120.13

0.7 (0.59%)

ANET

Arista Networks

$245.27

5.57 (2.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 31

    Oct

  • 05

    Nov

  • 05

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 08

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 19

    Nov

  • 20

    Nov

  • 09

    Dec

  • 12

    Dec

  • 16

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
10/21/19
10/21
13:17
10/21/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
10/21/19
10/21
13:16
10/21/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRM

Iron Mountain

$33.96

0.44 (1.31%)

13:15
10/21/19
10/21
13:15
10/21/19
13:15
Options
Iron Mountain put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 12

    Nov

BA

Boeing

$333.70

-10.39 (-3.02%)

13:05
10/21/19
10/21
13:05
10/21/19
13:05
Periodicals
Boeing CEO cites 'steady progress' on 737 MAX in internal email, Reuters says »

Boeing's CEO said in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

FTCH

Farfetch

$8.18

0.15 (1.87%)

13:05
10/21/19
10/21
13:05
10/21/19
13:05
Options
Farfetch Limited call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$299.80

1.815 (0.61%)

13:04
10/21/19
10/21
13:04
10/21/19
13:04
Periodicals
POTUS says trade pact with China coming along great, Reuters says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$299.80

1.815 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$118.45

0.96 (0.82%)

, MCD

McDonald's

$209.91

1.43 (0.69%)

13:03
10/21/19
10/21
13:03
10/21/19
13:03
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$118.45

0.96 (0.82%)

MCD

McDonald's

$209.91

1.43 (0.69%)

UTX

United Technologies

$138.27

1.42 (1.04%)

NEE

NextEra Energy

$231.47

-1.21 (-0.52%)

LMT

Lockheed Martin

$373.98

1.36 (0.36%)

UPS

UPS

$119.05

1.72 (1.47%)

SHW

Sherwin-Williams

$559.43

-1.54 (-0.27%)

KMB

Kimberly-Clark

$138.03

0.73 (0.53%)

BIIB

Biogen

$224.66

4.61 (2.10%)

TRV

Travelers

$141.76

0.32 (0.23%)

PCAR

Paccar

$73.44

1.39 (1.93%)

FITB

Fifth Third

$27.91

0.575 (2.10%)

CNC

Centene

$46.98

0.06 (0.13%)

RF

Regions Financial

$16.08

0.3 (1.90%)

NUE

Nucor

$52.25

0.56 (1.08%)

HAS

Hasbro

$120.60

-1.29 (-1.06%)

TRU

TransUnion

$82.01

0.52 (0.64%)

DGX

Quest Diagnostics

$102.55

-0.12 (-0.12%)

IPG

Interpublic Group

$20.69

0.04 (0.19%)

HOG

Harley-Davidson

$37.11

0.53 (1.45%)

PII

Polaris Industries

$92.01

1.395 (1.54%)

SNV

Synovus

$36.36

1.07 (3.03%)

JBLU

JetBlue

$17.63

0.675 (3.98%)

GPK

Graphic Packaging

$15.01

0.355 (2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 04

    Nov

  • 07

    Nov

  • 10

    Nov

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 19

    Nov

  • 04

    Dec

  • 07

    Dec

BMRN

BioMarin

$68.98

-0.18 (-0.26%)

13:03
10/21/19
10/21
13:03
10/21/19
13:03
Hot Stocks
BioMarin treatment of phenylketonuria granted FDA orphan status »

BioMarin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 23

    Oct

  • 07

    Dec

UPS

UPS

$119.07

1.74 (1.48%)

, FDX

FedEx

$153.86

3.97 (2.65%)

13:00
10/21/19
10/21
13:00
10/21/19
13:00
Earnings
Fly Intel: What to watch in UPS earnings report »

UPS (UPS) is scheduled to…

UPS

UPS

$119.07

1.74 (1.48%)

FDX

FedEx

$153.86

3.97 (2.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

  • 13

    Nov

  • 17

    Dec

AMTD

TD Ameritrade

$37.85

1.06 (2.88%)

, CDNS

Cadence Design

$66.73

1.13 (1.72%)

12:59
10/21/19
10/21
12:59
10/21/19
12:59
Earnings
Notable companies reporting after market close »

Notable companies…

AMTD

TD Ameritrade

$37.85

1.06 (2.88%)

CDNS

Cadence Design

$66.73

1.13 (1.72%)

CE

Celanese

$122.11

0.44 (0.36%)

ZION

Zions Bancorp

$45.40

0.68 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 06

    Nov

  • 19

    Nov

EL

Estee Lauder

$186.09

0.44 (0.24%)

12:56
10/21/19
10/21
12:56
10/21/19
12:56
Downgrade
Estee Lauder rating change  »

Estee Lauder downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.